Drug Profile
Dienogest - Bayer HealthCare Pharmaceuticals
Alternative Names: Visanne; BAY 865258; Dinagest; Endometrion®; M 18575; MJR-35; SH T00660AA; STS 557; VisanneLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Bayer Schering Pharma
- Developer Bayer HealthCare Pharmaceuticals; Bayer Zydus Pharma; Mochida Pharmaceutical
- Class Estrenes; Hormonal replacements; Oral contraceptives; Small molecules; Steroids; Testosterone congeners
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Dysmenorrhoea; Endometriosis; Menopausal syndrome; Pregnancy
- Phase III Adenomyosis